mepenzolate bromide

mepenzolate bromide

[mepen′zəlāt]
an anticholinergic/antispasmodic agent.
indications It is prescribed as an adjunct in treating peptic ulcers and preoperatively to reduce respiratory secretions.
contraindications Narrow-angle glaucoma, asthma, obstruction of the genitourinary or GI tract, severe ulcerative colitis, or known hypersensitivity to this drug prohibits its use.
adverse effects Blurred vision, central nervous system effects, tachycardia, dry mouth, decreased sweating, or hypersensitivity reactions may occur.

mepenzolate bromide

(məpenzōlāt brō´mīd),
n brand name: Cantil;
drug class: gastrointestinal (GI) anticholinergic;
action: inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites;
uses: treatment of peptic ulcer disease, irritable bowel syndrome in combination with other drugs, other GI disorders.